Fenretinide as an anti-angiogenic agent in neuroblastoma

Domenico Ribatti, Lizzia Raffaghello, Danilo Marimpietri, Emilio Cosimo, P. Giuseppe Montaldo, Beatrice Nico, Angelo Vacca, Mirco Ponzoni

Research output: Contribution to journalArticlepeer-review


Angiogenesis is a critical event in the progression of human neuroblastoma. This mini-review summarizes our literature and experimental data concerning the use of anti-angiogenic molecules, such as TNP-470 and fenretinide, in neuroblastoma treatment.

Original languageEnglish
Pages (from-to)181-184
Number of pages4
JournalCancer Letters
Issue number1-2
Publication statusPublished - Jul 18 2003


  • Angiogenesis
  • Anti-angiogenesis
  • Endothelial cells
  • Fenretinide
  • HPR
  • Neuroblastoma
  • Progression
  • Therapy
  • TNP-470
  • Vascular network

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology


Dive into the research topics of 'Fenretinide as an anti-angiogenic agent in neuroblastoma'. Together they form a unique fingerprint.

Cite this